{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:54:26Z","timestamp":1777517666946,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NCN grant","award":["2014\/15\/B\/NZ4\/05041"],"award-info":[{"award-number":["2014\/15\/B\/NZ4\/05041"]}]},{"name":"TauRx Therapeutics\/WisTa Laboratories Ltd., Singapore"},{"DOI":"10.13039\/501100014418","name":"Nencki Institute of Experimental Biology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014418","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jneumeth.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T23:30:27Z","timestamp":1542324627000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride"],"prefix":"10.1016","volume":"319","author":[{"given":"Anna","family":"Mietelska-Porowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gasiorowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Palasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave J.","family":"Koss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-6281","authenticated-orcid":false,"given":"Gernot","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazyna","family":"Niewiadomska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2018.11.009_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2018.03.023","article-title":"The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action","volume":"827","author":"Amidfar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0015","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1523\/JNEUROSCI.0188-12.2012","article-title":"Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027","volume":"32","author":"Barten","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2018.08.063","article-title":"Protein phosphatase 2A as therapeutic targets in various disease models","volume":"210","author":"Baskaran","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41398-017-0013-6","article-title":"Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons","volume":"7","author":"Bol\u00f3s","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer\u2019s disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0050","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1523\/JNEUROSCI.1487-05.2005","article-title":"Tyrosine 394 is phosphorylated in Alzheimer\u2019s paired helical filament Tau and in fetal Tau with c-Abl as the candidate tyrosine kinase","volume":"25","author":"Derkinderen","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2007-12405","article-title":"Memantine acts as a cholinergic stimulant in the mouse hippocampus","volume":"12","author":"Drever","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2051-5960-2-14","article-title":"Neuron-to neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies","volume":"2","author":"Dujardin","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","article-title":"Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression","volume":"73","author":"Ferrer","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2006-9101","article-title":"Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation","volume":"9","author":"Gong","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-4580(99)00063-9","article-title":"Memory and mental status correlates of modified Braak staging","volume":"20","author":"Grober","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1134\/S0006297917100029","article-title":"Molecular and Cellular Mechanisms of Sporadic Alzheimer\u2019s Disease: Studies on Rodent Models in vivo","volume":"82","author":"Gulyaeva","year":"2017","journal-title":"Biochemistry Mosc."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045881","article-title":"Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits","volume":"7","author":"Harris","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","article-title":"Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment","volume":"133","author":"Hatch","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1570159X14666160321123221","article-title":"Therapeutic modulation of glutamate receptors in major depressive disorder","volume":"15","author":"Jaso","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.10.064","article-title":"Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity","volume":"1309","author":"Kamat","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0110","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1007\/s00018-015-1949-4","article-title":"Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits","volume":"72","author":"Koss","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-016-1632-3","article-title":"Soluble pre-fibrillar tau and \u03b2-amyloid species emerge in early human Alzheimer\u2019s disease and track disease progression and cognitive decline","volume":"132","author":"Koss","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"18","key":"10.1016\/j.jneumeth.2018.11.009_bib0120","first-page":"30434","article-title":"Distinctive temporal profiles of detergent-soluble and -insoluble tau and A\u03b2 species in human Alzheimer\u2019s disease","volume":"S0006-8993","author":"Koss","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: Neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0130","first-page":"355","article-title":"Tauopathies. Handb","volume":"145","author":"Kovacs","year":"2017","journal-title":"Clin. Neurol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0135","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","article-title":"Phosphorylation of Tau by fyn: implications for Alzheimer\u2019s disease","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0140","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1899488","article-title":"A68: a major subunit of paired helical filaments and derivatized forms of normal Tau","volume":"251","author":"Lee","year":"1991","journal-title":"Science."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta condicional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"Matsunaga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2015.09.020","article-title":"Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0165","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.bjp.0705374","article-title":"Irreversible and reversible pore formation by polymeric alkylpyridinium salts (poly-APS) from the sponge Reniera sarai","volume":"139","author":"McClelland","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0170","article-title":"Lithium - pharmacological and toxicological aspects: the current state of the art","author":"Medi\u0107","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s000180050312","article-title":"Protein kinases: which one is the memory molecule? Cell","volume":"55","author":"Micheau","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0180","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0197-4580(95)00027-C","article-title":"Hyperphosphorylation of tau in PHF","volume":"16","author":"Morishima-Kawashima","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1196\/annals.1342.026","article-title":"Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats","volume":"1048","author":"Niewiadomska","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0195","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00702-006-0488-4","article-title":"Compartmental protein expression of Tau, GSK-3beta and TrkA in cholinergic neurons of aged rats","volume":"113","author":"Niewiadomska","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/REVNEURO.2006.17.6.581","article-title":"Cytoskeletal transport in the aging brain: focus on the cholinergic system","volume":"17","author":"Niewiadomska","year":"2006","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium chloride and risk for Alzheimer\u2019s disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0210","first-page":"104","article-title":"Microdose lithium chloride treatment stabilized cognitive impairment in patients with Alzheimer\u2019s disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0220","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2013"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3\u03b2 regulates production of Alzheimer\u2019s disease amyloid-b peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/syn.21965","article-title":"Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer\u2019s disease","volume":"71","author":"Pickett","year":"2017","journal-title":"Synapse."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0235","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta","volume":"19","author":"Qian","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0240","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0278-5846(02)00211-7","article-title":"No spatial working memory deficit in beta-amyloid exposed rats: a longitudinal study","volume":"26","author":"Roloff","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. & Biol. Psychiat."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1037\/0735-7044.116.2.351","article-title":"Working memory in aluminium and beta-amyloid exposed rats: a longitudinal study","volume":"116","author":"Roloff","year":"2002","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-004-0952-x","article-title":"Axonal transport defects: a common theme in neurodegenerative diseases","volume":"109","author":"Roy","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1471-4159.2008.05716.x","article-title":"Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation","volume":"108","author":"Sadik","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0260","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2174\/1381612043452686","article-title":"Protein phosphatase inhibition: structure based design. Towards new therapeutic agents","volume":"10","author":"Sakoff","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002320001078","article-title":"Analysis of the structure and electrophysiological actions of halitoxins: 1,3 alkyl-pyridinium salts from Callyspongia ridleyi","volume":"176","author":"Scott","year":"2000","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0270","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.febslet.2006.09.060","article-title":"Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level","volume":"580","author":"Sengupta","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0275","first-page":"139","article-title":"Bioactive alkylpyridinium compounds from marine sponges","volume":"19","author":"Sepcic","year":"2000","journal-title":"Toxin Rev."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0280","first-page":"47","article-title":"Biological activities of aqueous extracts from marine sponges and cytotoxic effects of 3-alkylpyridinium polymers from Reniera sarai","volume":"117","author":"Sepcic","year":"1997","journal-title":"Comparative biochemistry and physiology Part C: Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0285","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/awu046","article-title":"Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer\u2019s disease","volume":"137","author":"Shinohara","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","article-title":"Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment","volume":"11","author":"Sohn","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0295","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/NMM:2:2:151","article-title":"Axonal transport, tau protein, and neurodegeneration in Alzheimer\u2019s disease","volume":"2","author":"Terwel","year":"2002","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000067425","article-title":"Role of serine\/threonine protein phosphatase in Alzheimer\u2019s disease","volume":"11","author":"Tian","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0305","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2736(03)00175-5","article-title":"The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells","volume":"1614","author":"Tucker","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and Tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1523\/JNEUROSCI.22-01-00010.2002","article-title":"Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases","volume":"22","author":"Williamson","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0325","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/oxfordjournals.jbchem.a125011","article-title":"Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin","volume":"118","author":"Yamamoto","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.08.077","article-title":"An okadaic acid-induced model of tauopathy and cognitive deficiency","volume":"1359","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.11.009_bib0335","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/156720512804142877","article-title":"Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats","volume":"9","author":"Zimmer","year":"2012","journal-title":"Curr. Alzheimer Res."}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027018303789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027018303789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:48:41Z","timestamp":1759020521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027018303789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":67,"alternative-id":["S0165027018303789"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2018.11.009","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}